Sugi Predict

Sugi Predict / Compounds / SCHEMBL6094919

SCHEMBL6094919

SCHEMBL6094919

Cc1nc(N)c2ncn(CCCCN)c2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ADORA2A P29274 5/20 0.38
▸ CDK1 P06493 2/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ TLR7 Q9NYK1 4/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HRH2 P25021 1/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ NUDT1 P36639 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4793557 0.85 ALDH1A1 (0.37) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4794719 0.84 ALDH1A1 (0.39) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4791709 0.84 ALDH1A1 (0.36) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4791835 0.83 ADORA2A (0.36) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4793952 0.83 ALDH1A1 (0.38) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4793060 0.83 ALDH1A1 (0.36) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4794192 0.82 MAPK13 (0.37) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4794354 0.82 ALDH1A1 (0.45) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4793487 0.82 ALDH1A1 (0.38) ALDH1A1TDP1ADORA2ACDK1CCNB1
SCHEMBL4794870 0.81 ADORA2A (0.35) ALDH1A1TDP1ADORA2ACDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098221-B2 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-08-29 — — US disclosed
US-20050282854-A1 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2005-12-22 — — US disclosed
US-6969722-B2 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-11-29 — — US disclosed
US-6903113-B2 Urea substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-06-07 — — US disclosed
US-6878719-B2 Sulfonamido substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-04-12 — — US disclosed
US-20040186128-A1 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2004-09-23 — — US disclosed
EP-1453829-A1 SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-08 — — EP disclosed
EP-1451187-A1 AMIDE SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-01 — — EP disclosed
EP-1451186-A2 UREA SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-01 — — EP disclosed
US-20040157879-A1 Urea substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2004-08-12 — — US disclosed
US-20030195209-A1 Urea substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2003-10-16 — — US disclosed
US-20030186949-A1 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2003-10-02 — — US disclosed
US-20030176458-A1 Urea substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2003-09-18 — — US disclosed
US-20030162806-A1 Amide substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2003-08-28 — — US disclosed
WO-2003050118-A1 AMIDE SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 — — WO disclosed
WO-2003050119-A2 UREA SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 — — WO disclosed
WO-2003050117-A1 SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 — — WO disclosed
US-6545017-B1 Inducing cytokine biosynthesis; treating a viral and neoplastic diseases 3M INNOVATIVE PROPERTIES COMPANY 2003-04-08 — — US disclosed
US-6545016-B1 Inducing cytokine biosynthesis; treating a viral and neoplastic diseases 3M INNOVATIVE PROPERTIES COMPANY 2003-04-08 — — US disclosed
US-6525064-B1 Immune response modifiers; can induce the biosynthesis of various cytokines; 3M INNOVATIVE PROPERTIES COMPANY 2003-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186128-A1 Amide substituted imidazopyridines IRF3, EIF2AK2, IFNG ALDH1A1 1693/4885TDP1 3359/4885ADORA2A 2439/4885
US-20030176458-A1 Urea substituted imidazopyridines EIF2AK2, UMPS, IRF3 ALDH1A1 1975/4885TDP1 1345/4885ADORA2A 2559/4885
US-20030195209-A1 Urea substituted imidazopyridines EIF2AK2, UMPS, IRF3 ALDH1A1 1975/4885TDP1 1345/4885ADORA2A 2559/4885
US-20050282854-A1 Amide substituted imidazopyridines IRF3, EIF2AK2, IFNG ALDH1A1 1693/4885TDP1 3359/4885ADORA2A 2439/4885
US-20040157879-A1 Urea substituted imidazopyridines EIF2AK2, UMPS, IRF3 ALDH1A1 1975/4885TDP1 1345/4885ADORA2A 2559/4885
US-20030162806-A1 Amide substituted imidazopyridines IRF3, EIF2AK2, IFNG ALDH1A1 1693/4885TDP1 3359/4885ADORA2A 2439/4885
US-20030186949-A1 Amide substituted imidazopyridines IRF3, EIF2AK2, IFNG ALDH1A1 1693/4885TDP1 3359/4885ADORA2A 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.